Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review

Area of Science:

• Bone biology and metabolic disorders.
• Pharmacology and therapeutic interventions.
• Bioengineering and regenerative medicine.

Background:

• Osteoporosis is a significant public health issue, particularly in aging populations.
• Current treatments include anti-resorptive and anabolic agents, often used in combination.
• Understanding bone metabolism is crucial for effective osteoporosis management.

Purpose of the Study:

• To review current and emerging osteoporosis treatments.
• To detail molecular mechanisms, clinical evidence, and adverse effects of therapies.
• To guide clinicians in selecting optimal osteoporosis treatment strategies.

Main Methods:

• Comprehensive literature review of osteoporosis treatments.
• Analysis of molecular mechanisms of bone metabolism.
• Evaluation of clinical evidence and safety profiles of drugs.
• Exploration of advancements in bioengineering for future therapies.

Main Results:

• Established anti-resorptive agents (e.g., bisphosphonates) and anabolic agents (e.g., parathyroid hormone analogs) are key in current osteoporosis management.
• Emerging treatments like antibody agents, stem cells, and gene therapies show promise for future osteoporosis paradigms.
• Detailed understanding of drug efficacy, molecular actions, and potential side effects is essential for clinical decision-making.

Conclusions:

• Current osteoporosis treatments are effective but have limitations.
• Future therapeutic avenues leveraging molecular insights and bioengineering offer novel strategies for osteoporosis.
• Personalized treatment selection based on patient condition and drug profiles is paramount for managing osteoporosis.